# A Study to Evaluate the Safety of K-755 in Healthy Volunteers

> **NCT03414294** · PHASE1 · COMPLETED · sponsor: **Kowa Company, Ltd.** · enrollment: 121 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** K-755 Part A (SAD)
- **DRUG:** Placebo Part A (SAD)
- **DRUG:** K-755 Part B (MAD)
- **DRUG:** Placebo Part B (MAD)
- **DRUG:** K-755 Part C (FE)
- **DRUG:** K-755 Part D (FE)
- **DRUG:** K-755 Part E (MAD)
- **DRUG:** Placebo Part E (MAD)

## Key facts

- **NCT ID:** NCT03414294
- **Lead sponsor:** Kowa Company, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-27
- **Primary completion:** 2019-11-14
- **Final completion:** 2019-11-14
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2020-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03414294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03414294, "A Study to Evaluate the Safety of K-755 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03414294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*